Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-05-22 | Dec-31-21 | Dec-05-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 49.0 | 49.0 | 22.6 | 22.6 | 14.7 | 2.2 |
| Revenue growth | 116.9% | 116.9% | 53.9% | | 555.0% | |
| Cost of goods sold | 27.7 | 27.7 | 18.1 | 18.1 | 13.0 | 4.1 |
| Gross profit | 21.3 | 21.3 | 4.5 | 4.5 | 1.7 | -1.8 |
| Gross margin | 43.5% | 43.5% | 20.0% | 20.0% | 11.6% | -81.2% |
| Selling, general and administrative | 58.7 | 58.7 | 32.8 | 32.8 | 37.1 | 15.2 |
| Research and development | 26.0 | 26.0 | 24.5 | 24.5 | | 29.6 |
| EBIT | -63.3 | -63.3 | -52.8 | -52.8 | -35.4 | -46.1 |
| EBIT margin | -129.2% | -129.2% | -233.6% | -233.6% | -241.0% | -2055.8% |
| Pre-tax income | -66.7 | -66.7 | -48.7 | -48.7 | 27.6 | 126.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 |
| Tax rate | | | | | 0.2% | 0.0% |
| Net income | -66.8 | -66.8 | -48.7 | -48.7 | 27.6 | 126.2 |
| Net margin | -136.2% | -136.2% | -215.5% | -215.5% | 187.9% | 5632.3% |
| |
| Diluted EPS | ($2.41) | | ($3.57) | | $4.98 | $26,127.00 |
| Shares outstanding (diluted) | 27.7 | | 13.6 | | 5.5 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|